Le Lézard
Classified in: Health
Subjects: NPT, LAW

Allergy & Asthma Network Wins Jury Verdict In Antitrust Lawsuit By United Allergy Services


VIENNA, Va., March 26, 2018 /PRNewswire-USNewswire/ -- A San Antonio jury today returned a unanimous verdict in favor of Allergy & Asthma Network, the defendant in a federal antitrust lawsuit brought by United Allergy Services in early 2014.

"We are extremely pleased with the just and correct outcome of this case," Allergy & Asthma Network President and CEO Tonya Winders said. "We remained confident in a successful verdict throughout the entire 4-year process and the jury did a great job making this decision."

San Antonio-based United Allergy Services (UAS) had sued Allergy & Asthma Network/Mothers of Asthmatics and CEO Tonya Winders for $224 million. The Network is the leading nonprofit patient education and advocacy organization dedicated to ending needless death and suffering due to asthma, allergies and related conditions.

UAS accused the Network, leading allergist professional medical societies and Phadia/ThermoFisher Scientific of conspiring to organize a restraint of trade and restrict their business arrangements. All other defendants chose to settle due to the high cost of litigation; however, the Network and Winders refused to be silenced.

The jury determined the Network did not participate in a conspiracy nor did they interfere with UAS business practices. The jury also found the Network acted solely to protect patients and petition the government, as part of its First Amendment right.

"Thank you to each member of the eight-person jury who fulfilled his and her civic duty and supported patients' right to know when fraud, deception and abuse are occurring," Winders shared. "We are so grateful to our amazing legal team from the Carter Arnett firm based in Dallas, Texas."

About Allergy & Asthma Network

Allergy & Asthma Network is the leading national nonprofit organization dedicated to ending needless death and suffering due to asthma, allergies and related conditions. The Network specializes in sharing patient-friendly, medically reviewed information through its award-winning Allergy & Asthma Today magazine, E-newsletter, AllergyAsthmaNetwork.org and numerous community outreach programs.

Follow Allergy & Asthma Network on Facebook and Twitter @AllergyAsthmaHQ. Join at AllergyAsthmaNetwork.org/join.

Contact: Gary Fitzgerald
Allergy & Asthma Network
703-641-9595
[email protected]

SOURCE Allergy & Asthma Network


These press releases may also interest you

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...

at 17:15
Summary Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...

at 17:00
GBLT Corp. ("GBLT" or the "Company") announces that minority shareholders have approved the voluntary delisting (the "Delisting") of the common shares of the Company from the TSX Venture Exchange ("TSXV").  Approval for the delisting was received at...



News published on and distributed by: